Daily Roundup

Ai-Media Technologies charts growth trajectory with FY27 targets and buyback

Ai-Media Technologies is signaling confidence in its business momentum with a fresh set of financial targets and a significant capital return to shareholders. At its annual general meeting, the company guided for FY27 annual recurring revenue of $44-46 million, representing growth of 22-28% from the $36 million achieved in FY26. Total revenue is expected to land between $61-63 million, with adjusted EBITDA of $3.5-4.5 million.

The company's strategy centers on converting its established global presence—spanning 46 countries with more than 8,000 installed encoders—into sustainable earnings and cash generation. Management plans to scale its LEXI Text business while maintaining strong recurring margins, commercialize emerging capabilities like LEXI Voice, and broaden access through software integrations and partnerships.

Backing up its growth narrative, Ai-Media announced an on-market share buyback of up to 20.8 million shares, representing 9.9% of issued capital. The program, funded from existing cash reserves, kicks off on 26 October 2026 and will run for up to 12 months. Morgans Financial has been appointed to execute the purchases at prevailing market prices.

Black Cat Syndicate targets production ramp-up amid resource updates

Gold producer Black Cat Syndicate is gearing up for a busy year ahead, guiding for FY27 consolidated production of 80-90,000 ounces with all-in sustaining costs of $3,500-$3,900 per ounce. The company expects wholly owned production to jump 14-30% year-on-year, with its flagship Paulsens operation anticipated to grow by around 20%.

The ramp-up of Fingals and Majestic mines will weigh on unit costs in the first half, but Black Cat expects a turnaround in the second half as higher-grade ore comes online and cost optimization efforts take hold. Regulatory approval to boost processing capacity at Kal East to 1.5 million tonnes per annum should support this trajectory.

On the exploration front, the company is deploying $30-35 million across its portfolio. Paulsens will receive $13-15 million for near-mine and regional drilling, while Kal East gets a similar allocation focused on resource extension and conversion. Coyote will see $4-5 million directed toward infill drilling and extensions to the Axial Core Zone, with results expected to flow through in coming months.

The company's annual resource update reflects the reality of transitioning from developer to producer. Mineral resources fell 7% to 2.31 million ounces of gold, while ore reserves dropped 18% to 272,000 ounces, primarily due to mining depletion and updated geological models. Despite the declines, Black Cat retains a substantial base and is targeting significant growth through its disciplined exploration strategy.

Telix gets FDA Fast Track nod for prostate cancer imaging

Telix Pharmaceuticals has secured FDA Fast Track designation for its BiPASS program, a development that could accelerate the path to market for its prostate cancer diagnostic solution. The program combines gallium-68 PSMA-PET imaging with MRI to detect clinically significant prostate cancer before biopsy.

The Fast Track status is designed to expedite development and review of drugs addressing serious, unmet medical needs. Telix's technology has already demonstrated promise in earlier studies, cutting unnecessary biopsies by nearly 50 percent while improving detection rates. The designation builds on clinical work from the PRIMARY and PRIMARY2 studies, positioning the company to potentially bring this capability to patients more quickly.

Alcidion lands major NHS contract expansion

Healthcare software provider Alcidion has expanded its footprint in the UK's National Health Service with a new contract from Northern Care Alliance NHS Foundation Trust valued at $7.5 million over three years. The deal includes upgrading existing ExtraMed Flow systems at Salford Royal Hospital to Alcidion's newer Miya Flow platform and rolling out the solution across additional Trust sites.

Expected in-year revenue from the contract is approximately $4.5 million, including a six-month renewal of the existing ExtraMed subscription during the Miya Flow implementation phase. The contract includes options to extend for two additional years and expand to other modules, signaling potential for further growth within the Trust.

Orcoda appoints interim leadership as CEO search continues

Orcoda has appointed Geoffrey Jamieson, its current CFO and former managing director, as interim joint managing director on a temporary basis. The move ensures business continuity as the board continues hunting for a permanent CEO. Jamieson's existing CFO agreement is sufficient to cover the interim role, with no material changes to his employment terms.